| Biotechnology Industry | Healthcare Sector | Dr. Himani S. Dhotre CEO | XNSE Exchange | Y1R03Y104 CUSIP |
| India Country | 1,132 Employees | 12 Sep 2019 Last Dividend | 2 May 2016 Last Split | - IPO Date |
Dishman Carbogen Amcis Limited is an established entity in the pharmaceutical sector, providing an extensive range of contract research and manufacturing services on a global scale. With operations spanning both India and international markets, the company facilitates the pharmaceutical industry through two major segments: Contract Research and Manufacturing Services, and Marketable Molecules. Since its inception in 1983, Dishman Carbogen Amcis has grown into a reputable provider headquartered in Ahmedabad, India. It stands today as a significant subsidiary of Adimans Technologies LLP, exemplifying its strength and reliability in the pharmaceutical and chemical manufacturing domain.
The offerings of Dishman Carbogen Amcis Limited encompass a wide array of products and services significant to the pharmaceutical and cosmetic industries, among others. Here’s a detailed look at their varied portfolio: